Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
452
-
Total 13F shares, excl. options
-
43.3M
-
Shares change
-
+487K
-
Total reported value, excl. options
-
$10.2B
-
Value change
-
+$122M
-
Put/Call ratio
-
0.39
-
Number of buys
-
233
-
Number of sells
-
-188
-
Price
-
$235.64
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2022
518 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2022.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 452 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.3M shares
of 44.8M outstanding shares and own 96.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.31M shares), VANGUARD GROUP INC (4.25M shares), Avoro Capital Advisors LLC (2.97M shares), RENAISSANCE TECHNOLOGIES LLC (2.79M shares), FMR LLC (2.69M shares), STATE STREET CORP (1.57M shares), WELLINGTON MANAGEMENT GROUP LLP (1.45M shares), Bank of New York Mellon Corp (781K shares), Avidity Partners Management LP (726K shares), and JANUS HENDERSON GROUP PLC (708K shares).
This table shows the top 452 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.